| Financial Year |
March 31 2023 |
| Monetary Funds |
262,008,008.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
961,291,291.26 |
| Advances to Suppliers |
21,467,022.20 |
| Other Receivables |
280,103,606.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
169,388,575.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,870,697.36 |
| Total Current Assets |
2,352,233,664.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
143,090,790.77 |
| Investment Properties |
2,101,066.29 |
| Fixed Assetes |
229,768,345.44 |
| Under-construction Projects |
296,687,842.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,329,950.98 |
| R&D expenses |
-- |
| Goodwill |
9,682,335.61 |
| Long-Term Deferred and Prepaid Expenses |
658,964.71 |
| Deferred Income Tax Assets |
36,229,786.10 |
| Other Non-Current Assets |
1,813,422.14 |
| Sub-Total of Non-Current Assets |
942,572,461.02 |
| Total Assets |
3,294,806,125.25 |
| Short-Term Loans |
339,097,388.03 |
| Trading Financial liabilities |
63,953.68 |
| Notes Payable |
267,348,724.37 |
| Accounts Payable |
825,467,242.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,545,151.17 |
| Taxes Payable |
8,874,778.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
83,598,710.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
129,421,831.96 |
| Other Current Liabilities |
26,378.24 |
| Sub-Total of Current Liabilities |
1,744,595,699.04 |
| Long-term Loans |
87,270,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,865,847.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
147,812,713.33 |
| Total Liabilities |
1,892,408,412.37 |
| Paid-In Capital(Or Share Stock) |
185,252,160.00 |
| Capital Surplus |
620,670,246.06 |
| Surplus Reserve |
59,088,358.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
421,084,151.47 |
| Minority Stockholder's Interest |
41,960,708.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,360,437,004.04 |
| Owner's Equity（Stockholder's Equity） |
1,402,397,712.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,294,806,125.25 |
